Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Several July 2026 News Releases headlines were added (including CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer and the Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026). At the same time, older June 2026 items were removed from the list, updating the feed to reflect current and past news in the timeline.
    Difference
    4%
    Check dated 2026-07-27T06:29:50.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Adds two new News Releases announcing Trodelvy approvals in the U.S. and Europe, and removes two older items (Ouro Medicines acquisition and Seladelpar PBC trial results) from the News Releases list.
    Difference
    4%
    Check dated 2026-06-28T08:39:40.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new press release about FDA acceptance of Gilead’s investigational once-weekly Yeztugo is added to the News Releases, while an older press release about Livdelzi (Seladelpar) Phase 3 data is removed, reflecting an update to the News page.
    Difference
    4%
    Check dated 2026-06-20T22:25:32.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Four new News Releases were added (June 12, June 11, and June 8, 2026), expanding coverage of Gilead's latest activities, while four older items from May 21–22, 2026 were removed from the list.
    Difference
    4%
    Check dated 2026-06-13T17:56:24.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    Three June 2026 news items were added to the News Releases list, covering HIV prevention, an acquisition, and trial results, while older releases were removed to refresh the page’s content.
    Difference
    4%
    Check dated 2026-06-06T14:27:47.000Z thumbnail image
  9. Check
    64 days ago
    Change Detected
    Summary
    Adds a May 27, 2026 press release entry for Phase 3 ASSURE Interim Data on Livdelzi (Seladelpar) to the News Releases list, expanding the page with a new clinical update. Also removes the May 7, 2026 'Gilead Sciences Announces First Quarter Financial Results' entry from the list.
    Difference
    3%
    Check dated 2026-05-30T11:56:46.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.